Living in the 21st Century gives us all the ability to use some of the most advanced technologies of all-time. No matter the field of work, technology has been implemented into it to make the task at hand more efficient or progressive. The same goes for healthcare and the medical field. Some of the best modern day treatments have come out within the last 20 years and these treatments are far superior than the treatments of 30 and 40 years ago. Cancer Research has come along way throughout the years and now the tide is seemingly changing. Much of the gratitude goes toward a Biotechnology Company named Seattle Genetics. This company has been around since the late 90’s and has steadily grown into the powerhouse it is today. Seattle Genetics specializes in the development and commercialization of cancer breakthrough therapies. As of today this Bothell, Washington based organization is at the apex of the industry and it’s being run by one of the most brilliant minds in the game.
Dr. Clay Siegall is his name and eradicating cancer is his game. Dr. Siegall is well respected in the cancer research industry and he has a long list of accomplishments to backup all claims. Dr. Siegall has a Ph.D in Genetics from George Washington University as well as a (BS) from the University of Maryland. The good doctor has a strong passion for his craft and a great foundation in which he does business. The success of the company has grown dramatically over the years thanks to it’s advanced medications. The drug ADCETRIS is one of the top cancer fighting drugs on the market in which it has racked up $226 Million in sales last year in Canada and the U.S. Forbes named Seattle Genetics as one of the nations fastest growing companies in 2015.
Earlier this year Vice President Joe Bidden stopped by company headquarters for congratulatory purposes and the companies flagship drug ADCETRIS is now being used in over 65 countries worldwide. Clay Siegall is the epitome of the word revolution and his passion is certainly paying off.